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Closely associated with the antigen receptor molecule on the surface of human 
T  cells is the T3 complex composed of two glycoproteins with Mr of 25,000 (3' 
chain) and 20,000 (~ chain), and a nonglycosylated protein of Mr 20,000 (E chain) 
(1,  2).  Murine  mAb  have been  made  that  recognize the  human  T3  molecule. 
Physical association of the T3 molecule with the T  cell receptor (TCR) has been 
suggested by the ability of anti-T3 antibodies to coprecipitate a  and/3 chains of 
the TCR (3, 4). mAb directed against either T3 or the TCR induce the same T 
cell activation signal (5, 6). 
Because of its importance in human  T  cell function, we anticipated that the 
T3/TCR  complex would prove to be phylogenetically conserved. Recently (7- 
9), a murine T3 candidate has been identified by its coprecipitation with TCR 
and/3 chains.  Here we report evidence indicating the existence of a  functional 
T3/TCR  complex in birds. 
Materials and Methods 
Lymphocyte Isolation and Immunofluorescence.  Outbred white leghorn chickens, eggs, 
and young Indiana giant quails were obtained from local sources. Isolation of mononuclear 
cells  from  blood,  thymus,  bursa,  spleen,  and  bone  marrow,  and  immunofluorescent 
staining  were  as  described  (10,  11).  The  frequency of stained  cells  was  analyzed by 
fluorescence microscopy or automated flow cytometry. Capping of lymphocyte surface 
molecules after immunofluorescent staining was evaluated after incubation of stained cells 
for 30 rain at 37°C. 
Preparation ofmAb CT-3.  BALB/C mice were immunized by subcutaneous and footpad 
injections with  chicken thymocytes and  Ig- blood mononuclear cells,  and their lymph 
node ceils were fused with P3-X63Ag8.653 myeloma cells (11). One resultant hybridoma 
produced an IgG1, antibody, CT-3, showing immunofluorescence reactivity with a sub- 
population of blood lymphocytes. The hybridoma was subcloned, grown in ascites,  and 
the CT-3 antibody was purified on a protein A-Sepharose 4 B column. For mitogenicity 
studies, the purified CT-3 antibody was conjugated to Sepharose 4 B beads, and the exact 
amount of CT-3 bound to the beads calculated. 
Immunoprecipitation and Gel Electrophoresis.  Blood mononuclear ceils  were surface- 
labeled with NalZSl using the lactoperoxidase method, and lysed in either 1% NP-40 or 
1% digitonin plus 0.2%  NP-40 in 0.05 Tris, pH  7.5, containing protease inhibitors, at 
4°C for 30 min (9,  10). Immunoisolation was performed in a microtiter plate by a solid- 
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FIGURE  1.  a.  hnmunofluorescence analysis of cellular  rea&ivity with the CT-3  mAb. The 
results are presented as fluorescence histograms with the relative fluorescence intensity on a 
logarithmic scale.  Solid lines indicate the staining intensity of the cell-bound CT-3.  Dashed 
lines indicate staining of cells with a  control IgG1  mAb. b.  hnmunofluorescence analysis of 
the effect of enzyme treatment on CT-3 expression on blood mononuclear cells. Dashed lines 
indicate immunofluorescence intensity of cell-bound CT-3 before enzyme treatment, and solid 
lines indicate the staining intensity after pronase or neuraminidase treatment. The effect of 
trypsin treatment (not shown) was identical to that of pronase. 
phase method (11). CT-3-reactive molecules were dissociated from the plate by incubation 
with 2% SDS with or without 2-ME (reducing or nonreducing conditions) at 37°C for 1 
h, and examined by SDS-PAGE in the Laemmli system. 
Enzymatic Treatment.  Blood mononuclear cells  were  treated  wtih  1 mg/ml trypsin, 
pronase, or neuraminidase at 37°C for 30 min as described (11).  For endoglycosidase-F 
treatment, the  12~I-immunocomplex  was dissociated from microtiter wells by incubation 
with  100 mM Tris-HCI, pH 6.8, containing 1% SDS and  10 mM EDTA at 80°C for 20 
rain.  CT-3-reactive molecules were then digested with endoglycosidase-F at 37 °C for 4 h 
(9). 
[SH]Thymidine Incorporation.  Blood mononuclear cells were incubated with  the stim- 
ulating agent in RPMI-1640 culture medium containing 5% FCS in fiat-bottomed micro- 
titer plates  at 37°C in a  humdified atmosphere containing 5% CO2. After 3 d, the cells 
were pulsed with  1 #Ci [SH]thymidine for 18 h, and the samples were harvested using a 
semiautomatic cell harvester.  [~H]Thymidine incorporation was measured with a scintil- 
lation  counter. 
Results 
Tissue  Distribution  of Lymphocytes  Reactive  with  the  CT-3  Antibody.  Indirect 
immunofluorescence analysis  revealed  that  CT-3  antibody reacted  with  ~30% 
of thymocytes, 70%  of blood  mononuclear cells,  and  60%  of splenocytes,  but 
<1% of cells in the bursa and bone marrow (Fig.  1 a). When blood mononuclear 
cells were surface stained  either  with  CT-3,  the  M-4 anti-u mAb (10),  or CT-3 
plus M-4, 70, 23, and 93%, respectively, of the cells stained. This suggested that 
CT-3 + cells and IgM  + cells belong to separate lymphocyte populations, a conclu- 
sion that was confirmed when cells were examined by two-color immunofluores- 
cence for reactivity with  CT-3 or  M-4.  CT-3 was also found to react with  a  T 
cell  line (MDCC-CuI5/40), but  not with  the  B  cell  lines  (BK25,  249L4,  243L], CHEN  ET  AL.  BRIEF  DEFINITIVE  REPORT  377 
FIGURE 2.  a. CT-3-reactive surface proteins analyzed by SDS-PAGE. ~251-surface-labeled 
blood mononuclear cells were solubilized with NP-40 (lanes 1, 4, 5) or digitonin (lanes 2, 3, 
6). lmmunoprecipitates were prepared with CT-3 (lanes 1, 2, 5, 6) or a control mAb (lanes 3, 
4) and  analyzed on a  5-20%  gel  under nonreducing  (lanes 1-3) or reducing (lanes 4-6) 
•  "  125  conditions, b. Endoglycosidase-F  digestion of CT-3-reacuve proteins.  I-labeled  immunopre- 
cipitates prepared with CT-3 were digested with endoglycosidase-F  (lane 8). Undigested CT- 
3 imrnunoprecipitates were run in parallel (lane 7). 
293B9)  or  a  myeloid cell  line  (BM2)  tested.  CT-3  antigens  were  capped  after 
crosslinkage by the antibody, suggesting that CT-3 reacts with a surface molecule 
on chicken T  cells that has transmembrane connection to intracellular contractile 
elements. Quail lymphocytes, on the other hand, were not reactive with CT-3. 
Biochemical Characterization of CT-3-reactive Molecules.  Treatment of chicken 
T  cells with trypsin or pronase abolished CT-3  immunofluorescence reactivity, 
while  neuraminidase  treatment  increased  the  immunofluorescence  intensity 
slightly  (Fig.  I b).  SDS-PAGE  analysis  of the  CT-3-reactive  molecules  isolated 
from NP-40-solubilized T  ceils revealed three bands of Mr 20,000,  19,000, and 
17,000  under nonreducing conditions (Fig.  2a,  lane  i).  Under reducing condi- 
tions,  the apparent  sizes were  not altered significantly (lane 5).  Removal  of N- 
linked  sugars  from  the  isolated  CT-3-reactive  molecules  by endoglycosidase-F 
treatment  yielded  two  bands  of Mr  17,000  and  16,000  (Fig.  2b,  and  lane  8). 
These results suggest that the Mr 20,000 and 19,000 proteins were deglycosylated 
and  migrated  as  a  single  band  of  16,000,  while  the  Mr  17,000  protein  was 
unaffected. Identical results were obtained when the CT-3-reactive molecules on 
thymocytes and the Cu 15/40 T-cell line were examined. 
When  125I-labeled avian  T  cells were solubilized with digitonin,  CT-3  copre- 
cipitated  a  polypeptide of Mr  92,000  under  nonreducing  conditions  (Fig.  2a, 
lane 2), and two polypeptides of  Mr 49,000 and 37,000 under reducing conditions 
(Fig.  2a,  lane 6). 378  CHEN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
CT-3 Antibody Induces DNA Synthesis 
Stimulus of blood mononu- 
clear cells 
[SH]Thymidine incorporation  (cpm) at stimulus concentrations  0tg/ml) of: 
0  0.1  0.5  1.0  2.5  l0 
CT-3 (soluble  antibody)  322*  3,193  4,152  5,981  6,104  ND 
CT-3-Sepharose beads  322  6,197  21,645  38,854  18,422  N D 
Control  Sepharose beads  322  771  801  546  927  N D 
Con A  322  ND  ND  ND  ND  34,405 
* Numbers represent  [SHlthymidine  incorporation  by 106 cells from triplicate  cultures. 
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FIGURE  3.  Ontogeny  of CT-3 ÷ thymocytes  (0) and splenic cells (O) detected  by cell surface 
immunofluorescence.  Cell pools derived  from at least one dozen embryos  were used for each 
time point  during  the  embryonic  period.  Cells  from  one  chicken  were  used  for  each  point 
after hatching. 
Mitogenicity of CTo3 Antibody.  Mitogenic  activity  of  the  CT-3  antibody  on 
blood mononuclear cells  was examined  by  [~H]thymidine  uptake.  CT-3  conju- 
gated to Sepharose 4  B  beads induced a vigorous proliferative  response similar 
to  that  induced  by  Con  A,  while  soluble  CT-3  appeared  to  have  a  marginal 
mitogenic effect on T  cells (Table I). An unrelated IgG1  mAb conjugated to the 
beads had no demonstrable effect. 
Ontogeny of CT-3 Expression.  The  expression  of CT-3-reactive  molecules on 
thymocytes and splenocytes  was examined  by  immunofluorescence  microscopy 
from  embryonic  day  12  onward.  The  CT-3  antigen  was  present  on  -5%  of 
thymus  cells  from  12-d  chick  embryos.  The  frequency  of CT-3 +  thymocytes 
increased  to 25%  on day  14,  and remained  relatively  constant thereafter  until 
hatching on day 21. After hatching, the frequency ofCT-3 ÷ thymocytes increased 
to 50% over the first week of life, then decreased to 20-30%  throughout young 
adulthood  (Fig.  3).  Splenic  CT-3 +  lymphocytes  were  occasionally  observed  in 
embryonic  life,  but  their  frequency  remained  at  <1%  until  hatching.  The 
frequency of CT3 + splenocytes progressively increased thereafter  to reach 65% 
in young adults. CHEN  ET  AL.  BRIEF  DEFINITIVE  REPORT  379 
Discussion 
These studies provide the first evidence for existence of a T3/TCR complex 
in a nonmammalian  vertebrate. The avian T3 molecules consist of a complex of 
three  polypeptides  of MT  20,000,  19,000,  and  17,000,  two  of which  are  N- 
glycosylated. Thus the chicken  T3  complex appears  remarkably similar  to the 
T3 molecular complex in humans, which consists of two N-glycosylated polypep- 
tides and a  nonglycosylated polypeptide (1,  2).  The human  T3  E polypeptide is 
resistant  to  cell  surface  labeling  with  125I, but  it  can  be  radioiodinated  via  a 
hydrophobic labeling agent, and can be biosynthetically labeled (1).  In contrast, 
the candidate  T3  molecules in mouse consist of four or more polypeptides, all 
of which  can  be radioiodinated  by the  lactoperoxidase  method  (7-9) as is  the 
case  for  the  chicken  T3  polypeptides.  Further  studies  are  needed  to  identify 
homologies of the chains among the different representative species. 
The  human  T  cell  receptor  was  originally  recognized  with  anticlonotypic 
antibodies  (6,  12).  Its  a  (Mr  44,000)  and  /3  (MT  37,000)  chains  could  also be 
identified  as  minor  components  in  anti-T3  immunoprecipitates  isolated  from 
iodinated celt lysates (3, 4).  Using an improved extraction procedure (9), CT-3 
coprecipitated an polypeptide of Mr 92,000 from T  cell lysates, which could be 
reduced to two polypeptides of M~ 49,000 and 37,000. These results suggest the 
existence of a chicken TCR homolog containing a disulfide-linked heterodimer 
of a  and ~ chains associated with T3 molecules on the T  cell surface. 
The T  cell mitogenic effect of the CT-3 antibody on Sepharose beads provides 
further evidence that the antibody identifies the avian counterpart of the mam- 
malian T3/TCR complex. The marginal  effect of soluble CT-3 is probably due 
to low binding affinity of avian  Fc receptors for mammalian  Ig (13), as interac- 
tions of anti-human  T3 antibodies with monocyte Fc receptors are important in 
their mitogenic effects on T  cells. 
Hemopoietic stem cells colonized the avian thymic rudiment in waves, the first 
of which  is attracted  to the epithelial  thymus in  6.5-d-old chick embryos (14). 
Expression of cell surface antigens marking T-lineage  differentiation begins 5- 
6 d  later,  80% of embryonic thymocytes expressing the thymus specific antigen 
CT-1  by the  14th  embryonic day (11).  The  CT-3  antibody was reactive  with 
~5%  of thymocytes on  the  12th  day  of egg  incubation.  By day  14,  25%  of 
embryonic thymocytes expressed CT-3  molecules, and the Mr 92,000 heterodi- 
met could be detected in  the  CT-3  immunoprecipitate  (data  not shown).  The 
data suggest that a  5-6-d interval  of intrathymic  sojourn is required  for hemo- 
poietic stem cell progeny to reach the stage of T3/TCR expression, and another 
week of intrathymic  residence  before the  CT-3 + cells begin  to  migrate  to the 
spleen in significant numbers. 
The CT-3 antibody, which identifies the T3 complex on chicken and not quail 
T  cells, should be an ideal probe for examining the role of the T3/TCR complex 
in the development and function of T  cells. 
Summary 
A  mouse  mAb,  CT-3,  recognizes  on  chicken  T  cells  a  complex  of three 
polypeptides, Mr 20,000,  19,000, and  17,000, two of which are N-glycosylated. 
The  CT-3  antibody  is mitogenic for chicken  T  cells, and  it coprecipitates two 380  CHEN  ET  AL.  BRIEF  DEFINITIVE REPORT 
additional polypeptides of Mr 49,000 and 38,000 in lysates of T  cell membranes. 
Ontogeny studies  revealed  that  5-6  d  after thymic influx  of hemopoietic stem 
cells,  their  thymocyte progeny  begin  to  express  the  T3/TCR  complex.  After 
hatching  1 wk later, the CT-3 + cells begin splenic migration in large numbers. 
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